Inhibitors of Synaptic Vesicle Release: Botulinum and Tetanus Toxins
Synaptic Vesicle Release Overview
The brain is the headquarters of the central nervous system, playing a significant role in controlling and regulating human behavior and physiological processes, the functions of which principally depend on neurons, the basic units of the nervous system. Neural information is transmitted on neurons in the form of action potentials and between neurons (or among synapses) in the form of neurotransmitters. Generally, the neurotransmitters are released into the synaptic space and then act on the postsynaptic membrane, resulting in the next neuron being excitatory or inhibitory. The process that neurotransmitter in vesicles is released from presynaptic membrane to synaptic space by exocytosis is known as synaptic vesicle release.
The synaptic vesicle release is regulated by exocytosis in a voltage-dependent calcium channel manner. Molecules involved in the formation of synaptic vesicles, the fusion of vesicles to presynaptic membrane, the function of the calcium channel are closely related to synaptic vesicle release. While several neurotoxins or other inhibitors can restrain the synaptic vesicle release by affecting these biological processes.
Synaptic Vesicle Release Inhibitors
- Botulinum Toxin
Clostridium botulinum (C. botulinum), a Gram-positive, anaerobic, and spore-forming bacterium in the Clostridium genus, is characterized by the ability to produce botulinum exotoxins. Botulinum toxin is one of the most poisonous neurotoxins, comprising different 8 types (A, B, C1, C2, D, E, F, and G). Botulinum toxin A is a single polypeptide chain consisting of two disulfide-linked chains (a heavy chain and a light chain), which is the most potent neurotoxin. Although it was identified as neurotoxins, several botulinum-toxin drugs have been approved for clinical disease treatment.
All botulinum toxins act as neurotoxins by interfering with the transmission of neurotransmitters (mainly acetylcholine) by preventing the neurotransmitter vesicle release. During vesicle recycling, the botulinum toxin heavy chain can selectively and irreversibly bind to the presynaptic receptors. When the botulinum toxin-receptor complex is endocytosed into the neuron, the disulfide bond is cleaved through intravesical acidification, releasing the botulinum toxin into the cell. The botulinum toxin light chain in the cytoplasm can bind to and cleave vesicle or synaptosomal associated proteins to prevent neurotransmitter acetylcholine vesicles fuse with the presynaptic membrane, thereby blocking acetylcholine release. Recently, the neurotoxicity of botulinum toxin has been developed and exploited for treatment of a number of neurological conditions. Botulinum neurotoxin type A was approved by the Food and Drug Administration for treating migraines in 2010 and for bladder hyperactivity in 2011.
- Tetanus Toxin
Tetanus toxin, also known as tetanospasmin, is another kind of neurotoxin second only to the botulinum toxin, which is produced by the bacterium Clostridium tetani. Like botulinum neurotoxin, tetanus toxin also is a single polypeptide with a heavy chain and a light chain connected by a disulfide bond. The mechanism of tetanus toxin in synaptic vesicle release inhibition is different from botulinum neurotoxins.
Initially, tetanus toxin binds to the presynaptic terminals of the neuromuscular junction, and then is transported across synapses to the spinal cord, where tetanus toxin is finally transferred into inhibitory presynaptic terminals, such as GABAergic neurons and glycinergic neurons. Tetanus toxin in neuron reacts with and cleave the vesicle-associated membrane protein or synaptobrevin to prevent the release of inhibitory neurotransmitters (e.g., γ-aminobutyric acid and glycine), thereby enhancing the excitability of the motor neurons and leading to muscle hyperexcitability.
Creative Biolabs now provides a comprehensive range of high-quality products and tailored services for neurological research. Please directly contact us for detailed information if you are interested or have any questions.

- Mouse Anti-SCN5A Monoclonal Antibody (CBP708) (Cat#: NAB-0720-Z2720)
- iNeuMab™ Anti-F-Spondin/SPON1 Antibody, Clone 3F4 (Cat#: NRZP-0822-ZP4740)
- iNeuMab™ Mouse Anti-SHANK3 Monoclonal Antibody (CBP929) (Cat#: NAB-0720-Z3477)
- iNeuMab™ Mouse Anti-EFNB2 Monoclonal Antibody (CBP1159) (Cat#: NAB-0720-Z4396)
- iNeuMab™ Rabbit Anti-Alpha-synuclein (CBP1631) (Cat#: NAB-08-PZ079)
- iNeuMab™ Rabbit Anti-LRRK2 Monoclonal Antibody (CBP1887) (Cat#: NAB-08-PZ735)
- iNeuMab™ Mouse Anti-LRP1 Monoclonal Antibody (CBP3363) (Cat#: NAB-0720-Z6479)
- Mouse Anti-Human α-Synuclein Phospho (Tyr39) (CBP3706) (Cat#: NAB201250LS)
- Mouse Microglia N9 (Cat#: NCL2110P073)
- Green Fluorescent Alpha-synuclein Cell Line (Cat#: NCL2110P209)
- iNeu™ Human Oligodendrocyte Progenitor Cells (OPCs) (Cat#: NCL-2103-P49)
- Green Fluorescent Tau cell Line (Cat#: NCL2110P219)
- iNeu™ Human Motor Neurons (Cat#: NCL-2103-P71)
- Rat Olfactory Ensheathing Cells (Cat#: NRZP-1122-ZP162)
- Mouse Microglia Cell Line BV-2, Immortalized (Cat#: NCL2110P153)
- Human Microglia Cell Line HMC3, Immortalized (Cat#: NCL-2108P38)
- Rat Immortalized Retinal Muller Cell Line rMC-1 (Cat#: NCL-2106-S93)
- Mouse Midbrain Dopaminergic Neuron Cell MN9D (Cat#: NCL2110P059)
- Beta Amyloid (1-40), Aggregation Kit (Cat#: NRZP-0323-ZP199)
- Alpha Synuclein Aggregation Kit (Cat#: NRZP-1122-ZP15)
- Human GFAP ELISA Kit [Colorimetric] (Cat#: NPP2011ZP383)
- Alpha-Synuclein Aggregation Assay Kit (Cat#: NRZP-1122-ZP37)
- Human Tau Aggregation Kit (Cat#: NRP-0322-P2173)
- Beta Amyloid (1-42), Aggregation Kit (Cat#: NRZP-0323-ZP200)
- Human Poly ADP ribose polymerase,PARP Assay Kit (Cat#: NRZP-1122-ZP62)
- Amyloid beta 1-42 Kit (Cat#: NRP-0322-P2170)
- VSV-eGFP (Cat#: NTA-2011-ZP20)
- Dextran, NHS Activated (Cat#: NRZP-0722-ZP124)
- AAV2 Full Capsids, Reference Standards (Cat#: NTC2101070CR)
- Lenti of Mouse synuclein, alpha (Snca) transcript variant (NM_001042451) ORF clone, mGFP Tagged (Cat#: NEP-0521-R0864)
- Human huntingtin-associated protein 1 (HAP1) transcript variant 2 (NM_177977) ORF clone, Myc-DDK Tagged (Cat#: NEP-0521-R0676)
- Human presenilin 1 (PSEN1), transcript variant 2 (NM_007318) ORF clone, TurboGFP Tagged (Cat#: NEP-0421-R0140)
- Lenti of Human TAR DNA binding protein (TARDBP) (NM_007375) ORF clone, mGFP Tagged (Cat#: NEP-0521-R0832)
- App Rat amyloid beta (A4) precursor protein (App)(NM_019288) ORF clone, Untagged (Cat#: NEP-0421-R0053)
- Tau Antisense Oligonucleotide (IONIS-MAPTRx) (Cat#: NV-2106-P29)
- Mouse SOD1 shRNA Silencing Adenovirus (Cat#: NV-2106-P14)
- Rat Parkinson disease (autosomal recessive, juvenile) 2, parkin (Park2) (NM_020093) ORF clone/lentiviral particle, Myc-DDK Tagged (Cat#: NEP-0621-R0041)
- Mouse Parkinson disease (autosomal recessive, early onset) 7 (Park7) (NM_020569) clone, Untagged (Cat#: NEP-0621-R0133)
- ABCA1 Antisense Oligonucleotide (NV-2106-P27) (Cat#: NV-2106-P27)
- NeuroBiologics™ Rat Cerebrospinal Fluid (Cat#: NRZP-0822-ZP496)
- NeuroBiologics™ Human Cerebrospinal Fluid (Cat#: NRZP-0822-ZP491)
- NeuroBiologics™ Mouse Cerebrospinal Fluid (Cat#: NRZP-0822-ZP497)
- NeuroBiologics™ Pig Cerebrospinal Fluid (Cat#: NRZP-0822-ZP498)
- NeuroBiologics™ Monkey Cerebrospinal Fluid (Cat#: NRZP-0822-ZP495)
- NeuroPro™ Anti-IDUA BBB Shuttle Protein (Cat#: NRZP-0423-ZP498)
- NeuroPro™ Anti-PON1 BBB Shuttle Protein (Cat#: NRZP-0423-ZP507)
- NeuroPro™ Anti-NAGLU BBB Shuttle Protein (Cat#: NRZP-0423-ZP506)
- NeuroPro™ Anti-IDS BBB Shuttle Protein (Cat#: NRZP-0423-ZP503)
- NeuroPro™ Anti-ASA BBB Shuttle Protein (Cat#: NRZP-0423-ZP504)
- NeuroPro™ Anti-TNFR BBB Shuttle Protein (Cat#: NRZP-0423-ZP501)
- NeuroPro™ Anti-idursulfase BBB Shuttle Protein (Cat#: NRZP-0423-ZP497)
- NeuroPro™ Anti-GDNF BBB Shuttle Protein (Cat#: NRZP-0423-ZP500)
- NeuroPro™ Anti-Erythropoietin BBB Shuttle Protein (Cat#: NRZP-0423-ZP499)
- NeuroPro™ Anti-SGSH BBB Shuttle Protein (Cat#: NRZP-0423-ZP505)